Pfizer COVID-19 Vaccine Summary | Vaccines & Immunizations …
WEBAug 28, 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL …
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 · Individuals 5 years through 11 years of age regardless of previous vaccination are eligible to receive a single dose of the updated, authorized Moderna or Pfizer-BioNTech COVID-19 vaccines; if...
Pfizer–BioNTech COVID-19 vaccine - Wikipedia
WEBThe Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBDec 11, 2020 · The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to: prevent COVID-19 in individuals 12 years of age and older, and. provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise.
Pfizer-BioNTech COVID-19 Vaccine | FDA
WEBSep 11, 2023 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19. The Pfizer-BioNTech...
FDA Approves First COVID-19 Vaccine
WEBFDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEB2 days ago · Your child should NOT get Pfizer-BioNTech COVID-19 Vaccine if they had a severe allergic reaction after a previous dose of any Pfizer-BioNTech COVID-19 vaccine or to any ingredients in these vaccines; There is a remote chance that the vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a …
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …
WEBSep 22, 2021 · NEW YORK & MAINZ, Germany-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 …
Grading of Recommendations, Assessment, Development, and …
WEBAug 21, 2024 · Introduction. On August 23, 2021, the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for Pfizer-BioNTech COVID-19 Vaccine (COMIRNATY®) for the prevention of COVID-19 in individuals aged ≥16 years. 35 As part of the process employed by the Advisory Committee for Immunization Practices (ACIP), a systematic review and Grading of Recommendations ...
The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you …
WEBAug 18, 2022 · According to SAGE, the Pfizer-BioNTech COVID-19 mRNA vaccine is safe and effective. Who can take the vaccine? The vaccine is safe and effective for all individuals aged 6 months and above.
Skip to content